首页> 外国专利> Inhibition of caspase-1 and its use for prevention and treatment of neurological conditions

Inhibition of caspase-1 and its use for prevention and treatment of neurological conditions

机译:caspase-1的抑制及其在神经疾病预防和治疗中的用途

摘要

Preventing a neurological condition (eg, a neurodegenerative disease (eg, Alzheimer's disease)) in a subject, delaying its onset or reducing its severity, preventing its progression, or preventing its progression, based on caspase 1 inhibition Methods for retreating or treating are described herein. Also described herein are methods of preventing cognitive impairment, delaying its onset or reducing its severity, preventing or reversing its progression, or treating its progression in a subject based on caspase-1 inhibition. . Corresponding uses and kits are also described. In one embodiment, the caspase 1 inhibitor is VX-765 or a pharmaceutically acceptable salt thereof.
机译:基于胱天蛋白酶1抑制作用,预防受试者的神经系统疾病(例如,神经退行性疾病(例如,阿尔茨海默氏病)),延迟其发作或降低其严重性,防止其进展或阻止其进展,描述了用于后退或治疗的方法在这里。本文还描述了基于胱天蛋白酶-1抑制作用在受试者中预防认知障碍,延迟其发作或降低其严重性,预防或逆转其进展或治疗其进展的方法。 。还描述了相应的用途和套件。在一个实施方案中,胱天蛋白酶1抑制剂是VX-765或其药学上可接受的盐。

著录项

  • 公开/公告号JP2020502282A

    专利类型

  • 公开/公告日2020-01-23

    原文格式PDF

  • 申请/专利权人 ルブラン;アンドレア;

    申请/专利号JP20190555521

  • 发明设计人 ルブラン;アンドレア;

    申请日2017-12-20

  • 分类号A61K31/4025;A61K45;A61P25;A61P25/28;C07D405/12;

  • 国家 JP

  • 入库时间 2022-08-21 11:34:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号